Union Korea Pharm Co., Ltd. announced a private placement of series 4 unsecured convertible bonds for the gross proceeds of KRW 5,000,000,000 on April 25, 2024. The bonds will be convertible into 801,796 common shares at a price of KRW 6,236 per share. The bonds will have a coupon rate of 3% and will have a maturity rate of 4%.

The bonds will be matured on May 10, 2027. The transaction has been approved by the shareholders of the company and is expected to close on May 10, 2024. The transaction will include participation from new investors, Mark420 Co., Ltd for KRW 1,500,000,000, NBH Capital Inc. for KRW 500,000,000, JW Global No.1 Fund for KRW 2,000,000,000, SB Medico Co., Ltd for KRW 1,000,000,000.